Global Oral Transmucosal Drugs Market to Surpass $35 Billion by 2034, Rapid Growth Predicted in Asia-Pacific Propelled by Developments in Healthcare Infrastructure Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Oral Transmucosal Drugs Market by Product Type, Route of Administration, Indication, Distribution Channel, and By Region" report has been added...

Orally Disintegrating Tablet Market Report: Expanded Analysis, Trends, and Forecasts to 2031 Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...

Update: Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent (re-release) Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US  9,901,545  (the “’545 Patent”) concerning the manufacture of oral thin film...

Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US  9,901,545  (the “’545 Patent”) concerning the manufacture of oral thin film...

FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of...